Medicines

For help on how to get the results you want, see our search tips.

Search results

1442 results

Sort by

List item

Ibutilide: List of nationally authorised medicinal products - PSUSA/00001713/201712 (PDF/80.23 KB)

Last updated: 10/09/2018
Active substance: ibutilide
Procedure number: PSUSA/00001713/201712
Regulatory outcome: Maintenance
List item

Dutasteride, dutasteride / tamsulosine: List of nationally authorised medicinal products - PSUSA/00010506/201711 (PDF/188.56 KB)

Last updated: 14/08/2018
Active substance: dutasteride, tamsulosin
Procedure number: PSUSA/00010506/201711
Regulatory outcome: Maintenance
List item

Glatiramer: List of nationally authorised medicinal products - PSUSA/00001529/201711 (PDF/277.02 KB)

Last updated: 14/08/2018
Active substance: glatiramer
Procedure number: PSUSA/00001529/201711
Regulatory outcome: Maintenance
List item

Antithrombin iii: List of nationally authorised medicinal products - PSUSA/00003159/201712 (PDF/220.23 KB)

Last updated: 14/08/2018
Active substance: antithrombin iii
Procedure number: PSUSA/00003159/201712
Regulatory outcome: Maintenance
List item

Alfuzosin: List of nationally authorised medicinal products - PSUSA/00000084/201711 (PDF/300.84 KB)

Last updated: 14/08/2018
Active substance: alfuzosin
Procedure number: PSUSA/00000084/201711
Regulatory outcome: Maintenance
List item

Levocabastine: List of nationally authorised medicinal products - PSUSA/00001849/201711 (PDF/115.5 KB)

Last updated: 19/07/2018
Active substance: levocabastine
Procedure number: PSUSA/00001849/201711
Regulatory outcome: Maintenance
List item

Amlodipine / indapamide, amlodipine / indapamide / perindopril: List of nationally authorised medicinal products - PSUSA/00010358/201711 (PDF/457.81 KB)

Last updated: 19/07/2018
Active substance: perindopril, indapamide, amlodipine
Procedure number: PSUSA/00010358/201711
Regulatory outcome: Maintenance
List item

Abciximab: List of nationally authorised medicinal products - PSUSA/00000014/201711 (PDF/88.3 KB)

Last updated: 19/07/2018
Active substance: abciximab
Procedure number: PSUSA/00000014/201711
Regulatory outcome: Maintenance
List item

Fludeoxyglucose (18f): List of nationally authorised medicinal products - PSUSA/00001437/201711 (PDF/91.73 KB)

Last updated: 19/07/2018
Active substance: fludeoxyglucose (18F)
Procedure number: PSUSA/00001437/201711
Regulatory outcome: Maintenance
List item

Tafluprost / timolol: List of nationally authorised medicinal products - PSUSA/00010324/201712 (PDF/116.22 KB)

Last updated: 19/07/2018
Active substance: Tafluprost, timolol
Procedure number: PSUSA/00010324/201712
Regulatory outcome: Maintenance
List item

Diphtheria / tetanus / pertussis (acellular, component) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed): List of nationally authorised medicinal products - PSUSA/00001124/201711 (PDF/280.62 KB)

Last updated: 19/07/2018
Active substance: haemophilus type b conjugate vaccine (adsorbed), poliomyelitis (inactivated), pertussis (acellular, component), tetanus, diphtheria vaccine
Procedure number: PSUSA/00001124/201711
Regulatory outcome: Maintenance
List item

Caffeine / drotaverine hydrochloride / metamizol sodium: List of nationally authorised medicinal products - PSUSA/00001996/201711 (PDF/68.05 KB)

Last updated: 19/07/2018
Active substance: metamizol sodium, drotaverine hydrochloride, Caffeine
Procedure number: PSUSA/00001996/201711
Regulatory outcome: Maintenance
List item

Cetirizine: List of nationally authorised medicinal products - PSUSA/00000628/201711 (PDF/254.51 KB)

Last updated: 18/07/2018
Active substance: cetirizine
Procedure number: PSUSA/00000628/201711
Regulatory outcome: Maintenance
List item

Bambuterol: List of nationally authorised medicinal products - PSUSA/00000295/201712 (PDF/72.79 KB)

Last updated: 18/07/2018
Active substance: bambuterol
Procedure number: PSUSA/00000295/201712
Regulatory outcome: Maintenance
List item

Clevidipine: List of nationally authorised medicinal products - PSUSA/00010288/201711 (PDF/74.97 KB)

Last updated: 18/07/2018
Active substance: clevidipine
Procedure number: PSUSA/00010288/201711
Regulatory outcome: Maintenance
List item

Econazole, econazole nitrate / triamcinolone acetonide, econazole nitrate / zinc oxide: List of nationally authorised medicinal products - PSUSA/00001195/201711 (PDF/115.46 KB)

Last updated: 18/07/2018
Active substance: zinc oxide, econazole, econazole nitrate, Triamcinolone acetonide
Procedure number: PSUSA/00001195/201711
Regulatory outcome: Maintenance
List item

Amino acid combinations / glucose / triglyceride combinations / with or without electrolytes / mineral compounds - only for the drug Numeta: List of nationally authorised medicinal products - PSUSA/00010190/201712 (PDF/117.69 KB)

Last updated: 18/07/2018
Active substance: triglyceride combinations, glucose, amino acid combinations
Procedure number: PSUSA/00010190/201712
Regulatory outcome: Maintenance
List item

Rupatadine: List of nationally authorised medicinal products - PSUSA/00002673/201712 (PDF/162.42 KB)

Last updated: 18/07/2018
Active substance: rupatadine
Procedure number: PSUSA/00002673/201712
Regulatory outcome: Maintenance
List item

Methylprednisolone: List of nationally authorised medicinal products - PSUSA/00002026/201711 (PDF/371.88 KB)

Last updated: 17/07/2018
Active substance: methylprednisolone
Procedure number: PSUSA/00002026/201711
Regulatory outcome: Maintenance
List item

Bromperidol: List of nationally authorised medicinal products - PSUSA/00000439/201711 (PDF/72.7 KB)

Last updated: 17/07/2018
Active substance: bromperidol
Procedure number: PSUSA/00000439/201711
Regulatory outcome: Maintenance
List item

Diacerein: List of nationally authorised medicinal products - PSUSA/00001026/201712 (PDF/96.71 KB)

Last updated: 17/07/2018
Active substance: Diacerein
Procedure number: PSUSA/00001026/201712
Regulatory outcome: Maintenance
List item

Carvedilol / ivabradine: List of nationally authorised medicinal products - PSUSA/00010586/201711 (PDF/286.77 KB)

Last updated: 29/06/2018
Active substance: Carvedilol, ivabradine
Procedure number: PSUSA/00010586/201711
Regulatory outcome: Maintenance
List item

Hydroxyzine chloride / hydroxyzine pamoate and all fixed combination, hydroxyzine: List of nationally authorised medicinal products - PSUSA/00001696/201711 (PDF/111.47 KB)

Last updated: 22/06/2018
Active substance: hydroxyzine, hydroxyzine pamoate, hydroxyzine chloride
Procedure number: PSUSA/00001696/201711
Regulatory outcome: Maintenance
List item

Methoxyflurane: List of nationally authorised medicinal products - PSUSA/00010484/201711 (PDF/70.32 KB)

Last updated: 22/06/2018
Active substance: Methoxyflurane
Procedure number: PSUSA/00010484/201711
Regulatory outcome: Maintenance
List item

Ezetimibe: List of nationally authorised medicinal products - PSUSA/00001346/201710 (PDF/132.02 KB)

Last updated: 22/06/2018
Active substance: Ezetimibe
Procedure number: PSUSA/00001346/201710
Regulatory outcome: Maintenance

1442 results

Ibutilide: List of nationally authorised medicinal products - PSUSA/00001713/201712 (PDF/80.23 KB)

Dutasteride, dutasteride / tamsulosine: List of nationally authorised medicinal products - PSUSA/00010506/201711 (PDF/188.56 KB)

Glatiramer: List of nationally authorised medicinal products - PSUSA/00001529/201711 (PDF/277.02 KB)

Antithrombin iii: List of nationally authorised medicinal products - PSUSA/00003159/201712 (PDF/220.23 KB)

Alfuzosin: List of nationally authorised medicinal products - PSUSA/00000084/201711 (PDF/300.84 KB)

Levocabastine: List of nationally authorised medicinal products - PSUSA/00001849/201711 (PDF/115.5 KB)

Amlodipine / indapamide, amlodipine / indapamide / perindopril: List of nationally authorised medicinal products - PSUSA/00010358/201711 (PDF/457.81 KB)

Abciximab: List of nationally authorised medicinal products - PSUSA/00000014/201711 (PDF/88.3 KB)

Fludeoxyglucose (18f): List of nationally authorised medicinal products - PSUSA/00001437/201711 (PDF/91.73 KB)

Tafluprost / timolol: List of nationally authorised medicinal products - PSUSA/00010324/201712 (PDF/116.22 KB)

Diphtheria / tetanus / pertussis (acellular, component) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed): List of nationally authorised medicinal products - PSUSA/00001124/201711 (PDF/280.62 KB)

Caffeine / drotaverine hydrochloride / metamizol sodium: List of nationally authorised medicinal products - PSUSA/00001996/201711 (PDF/68.05 KB)

Cetirizine: List of nationally authorised medicinal products - PSUSA/00000628/201711 (PDF/254.51 KB)

Bambuterol: List of nationally authorised medicinal products - PSUSA/00000295/201712 (PDF/72.79 KB)

Clevidipine: List of nationally authorised medicinal products - PSUSA/00010288/201711 (PDF/74.97 KB)

Econazole, econazole nitrate / triamcinolone acetonide, econazole nitrate / zinc oxide: List of nationally authorised medicinal products - PSUSA/00001195/201711 (PDF/115.46 KB)

Amino acid combinations / glucose / triglyceride combinations / with or without electrolytes / mineral compounds - only for the drug Numeta: List of nationally authorised medicinal products - PSUSA/00010190/201712 (PDF/117.69 KB)

Rupatadine: List of nationally authorised medicinal products - PSUSA/00002673/201712 (PDF/162.42 KB)

Methylprednisolone: List of nationally authorised medicinal products - PSUSA/00002026/201711 (PDF/371.88 KB)

Bromperidol: List of nationally authorised medicinal products - PSUSA/00000439/201711 (PDF/72.7 KB)

Diacerein: List of nationally authorised medicinal products - PSUSA/00001026/201712 (PDF/96.71 KB)

Carvedilol / ivabradine: List of nationally authorised medicinal products - PSUSA/00010586/201711 (PDF/286.77 KB)

Hydroxyzine chloride / hydroxyzine pamoate and all fixed combination, hydroxyzine: List of nationally authorised medicinal products - PSUSA/00001696/201711 (PDF/111.47 KB)

Methoxyflurane: List of nationally authorised medicinal products - PSUSA/00010484/201711 (PDF/70.32 KB)

Ezetimibe: List of nationally authorised medicinal products - PSUSA/00001346/201710 (PDF/132.02 KB)